Medical Health Cluster

Variants

Variant Proportions

Variants of SARS-CoV-2, the virus that causes COVID-19, are expected to continue to emerge. Some will emerge and disappear, and others will emerge and continue to spread and may replace previous variants. For example, the variant of the virus that caused the first U.S. COVID-19 cases in January 2020 is […]

Read More

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Abstract SARS-CoV-2 mutations may diminish vaccine-induced protective immune responses, particularly as antibody titers wane over time. Here, we assess the impact of SARS-CoV-2 variants B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.429 (Epsilon), B.1.526 (Iota), and B.1.617.2 (Delta) on binding, neutralizing, and ACE2-competing antibodies elicited by the vaccine mRNA-1273 over seven […]

Read More

Indoor Masking Needed in Almost 70% of US Counties: CDC Data

In announcing new guidance on Tuesday, the CDC said vaccinated people should wear face masks in indoor public places with “high” or “substantial” community transmission rates of COVID-19. Data from the CDC shows that designation covers 69.3% of all counties in the United States — 52.2% (1,680 counties) with high community transmission rates […]

Read More

SARS-CoV-2 Variant Classifications and Definitions

Viral mutations and variants in the United States are routinely monitored through sequence-based surveillance, laboratory studies, and epidemiological investigations. A US government SARS-CoV-2 Interagency Group (SIG) developed a Variant Classification scheme that defines three classes of SARS-CoV-2 variants: Variant of Interest Variant of Concern Variant of High Consequence The B.1.1.7 (Alpha), B.1.351 […]

Read More

Pfizer insiste en la necesidad de una tercera dosis para enfrentar la variante Delta

Según un estudio interno de la farmacéutica, la efectividad de su vacuna desciende una media de un 6% entre el cuarto y sexto mes después de recibir la pauta completa. Este miércoles, la farmacéutica estadounidense Pfizer ha presentado nuevos datos de un estudio propio que sugieren que una tercera dosis de la vacuna contra la […]

Read More